1. Home
  2. MYGN vs GOGL Comparison

MYGN vs GOGL Comparison

Compare MYGN & GOGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • GOGL
  • Stock Information
  • Founded
  • MYGN 1991
  • GOGL N/A
  • Country
  • MYGN United States
  • GOGL Bermuda
  • Employees
  • MYGN N/A
  • GOGL N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GOGL Marine Transportation
  • Sector
  • MYGN Health Care
  • GOGL Consumer Discretionary
  • Exchange
  • MYGN Nasdaq
  • GOGL Nasdaq
  • Market Cap
  • MYGN 2.0B
  • GOGL 1.8B
  • IPO Year
  • MYGN 1995
  • GOGL 1997
  • Fundamental
  • Price
  • MYGN $12.39
  • GOGL $8.86
  • Analyst Decision
  • MYGN Hold
  • GOGL Hold
  • Analyst Count
  • MYGN 12
  • GOGL 2
  • Target Price
  • MYGN $23.92
  • GOGL $12.25
  • AVG Volume (30 Days)
  • MYGN 1.0M
  • GOGL 1.4M
  • Earning Date
  • MYGN 02-25-2025
  • GOGL 02-28-2025
  • Dividend Yield
  • MYGN N/A
  • GOGL 13.54%
  • EPS Growth
  • MYGN N/A
  • GOGL 102.13
  • EPS
  • MYGN N/A
  • GOGL 1.22
  • Revenue
  • MYGN $823,600,000.00
  • GOGL $1,011,652,000.00
  • Revenue This Year
  • MYGN $13.82
  • GOGL N/A
  • Revenue Next Year
  • MYGN $4.59
  • GOGL $2.75
  • P/E Ratio
  • MYGN N/A
  • GOGL $7.27
  • Revenue Growth
  • MYGN 12.15
  • GOGL 14.81
  • 52 Week Low
  • MYGN $12.17
  • GOGL $8.52
  • 52 Week High
  • MYGN $29.30
  • GOGL $15.77
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 29.80
  • GOGL 39.47
  • Support Level
  • MYGN $12.17
  • GOGL $9.07
  • Resistance Level
  • MYGN $15.08
  • GOGL $9.52
  • Average True Range (ATR)
  • MYGN 0.79
  • GOGL 0.22
  • MACD
  • MYGN -0.01
  • GOGL 0.07
  • Stochastic Oscillator
  • MYGN 7.56
  • GOGL 18.52

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

About GOGL Golden Ocean Group Limited

Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts.

Share on Social Networks: